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Summary
Short antimicrobial host-defense peptides represent
a possible alternative as lead structures to fight antibi-
otic resistant bacterial infections. Bac2A is a 12-mer
linear variant of the naturally occurring bovine host
defense peptide, bactenecin, and demonstrates mod-
erate, broad-spectrum antimicrobial activity against
Gram-positive and Gram-negative bacteria as well as
against the yeast Candida albicans. With the assis-
tance of amethod involving peptide synthesis on a cel-
lulose support, the primary sequence requirements
for antimicrobial activity against the human patho-
gen Pseudomonas aeruginosa of 277 Bac2A variants
were investigated by using a luciferase-based assay.
Sequence scrambling of Bac2A led to activities rang-
ing from superior or equivalent to Bac2A to inactive,
indicating that good activity was not solely dependent
on the composition of amino acids or the overall
charge or hydrophobicity, but rather required particu-
lar linear sequence patterns. A QSAR computational
analysis was applied to analyze the data resulting in
a model that supported this sequence pattern hypoth-
esis. The activity of selected peptides was confirmed
by conventional minimal inhibitory concentration
(MIC) analyses with a panel of human pathogen bacte-
ria and fungi. Circular-dichroism (CD) spectroscopy
with selected peptides in liposomes and membrane
*Correspondence: bob@cmdr.ubc.cadepolarization assays were consistent with a relation-
ship between structure and activity. An additional op-
timization process was performed involving system-
atic amino acid substitutions of one of the optimal
scrambled peptide variants, resulting in superior ac-
tive peptide variants. This process provides a cost
and time effective enrichment of new candidates for
drug development, increasing the chances of finding
pharmacologically relevant peptides.
Introduction
Antibiotic therapy is under severe pressure due to
increased antibiotic resistance. According to the 2004
report of the National Nosocomial Infection Surveillance
(NNIS) [1], the rate of resistance to methicillin of coagu-
lase-negative Staphylococci (CNS) reached 89.1%,
while that of Staphylococcus aureus (well known as
MRSA) increased to 59%. Similar trends were seen for
other pathogenic bacteria against third-generation
cephalosporins such as ceftriaxone, cefotaxime, and
ceftazidime, for example, Klebsiella pneumoniae for
which resistance increased nearly 2-fold to reach
20.6% and Pseudomonas aeruginosa, which had be-
come 31.9% resistant.
Cationic antimicrobial peptides provide potential tem-
plates for a new generation of antimicrobials. They kill
microorganisms rapidly and directly, demonstrate syn-
ergy with conventional antibiotics, and in some cases,
activate host innate immunity. Moreover, some seem
to counteract harmful inflammatory/septic responses
induced by bacterial endotoxin [2], which is extremely
important since rapid killing of bacteria and subsequent
liberation of bacterial components such as LPS or pep-
tidoglycan can induce potentially fatal immune dysregu-
lation [3, 4].
The bovine cationic peptide bactenecin (also called
dodecapeptide) is one of the smallest naturally occur-
ring antimicrobial peptides. It was discovered in bovine
neutrophils by Romeo et al. in 1988 [5]. Bactenecin
(RLCRIVVIRVCR) is stabilized by an internal disulfide
bridge and is moderately active against Gram-negative
bacteria and against certain Gram-positive bacteria
(e.g., S. pyogenes, C. xerosis). A linear variant, Bac2A
(RLARIVVIRVAR-NH2), in which the cysteine residues
were replaced with alanines, showed similar activity
against Gram-negative bacteria but improved activity
against Gram-positive bacteria [6]. The features of
Bac2A, namely small size, linearity, and activity against
both Gram-positive and Gram-negative bacteria, make
this peptide an ideal lead structure to develop new anti-
microbial drugs.
There are hundreds of cationic peptides from nature
with a wide variety of sequences, structures, and spectra
of activity that vary substantially in potency [7]. This di-
versity is matched by a number of complex and conten-
tious models that attempt to describe and explain their
modes of action, although central to their mode of action
is their ability to interact with membranes [8]. Previously,
detailed studies of primary sequence requirements were
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1102Table 1. Substitution Analysis of a Single Position of Three Different Peptides
Original
Sequence
Activity Relative to the Parent Peptide with Different Substituted Amino Acidsa
A C D E F G H I K L M N P Q R S T V W Y
RLARIVVIRVARa 6.3 2.5 13.6 19.4 5.5 4.3 3.8 3.1 2.7 4.4 5.1 5.4 9.4 5.5 2.3 5.8 5.3 5.7 5.4 3.2
RLWRIVVIRVAR 1.0 3.9 12.9 12.4 3.5 1.3 1.0 2.5 0.2 2.0 1.6 0.8 1.2 1.2 0.7 1.4 2.1 2.1 2.5 3.1
RLRRIVVIRVAR 1.0 0.9 3.2 2.7 0.5 1.0 0.6 1.0 0.6 0.7 0.8 1.0 1.7 0.9 0.6 1.1 1.3 0.9 0.6 0.5
The amino acids, given in the one letter code, are substituted against the underlined and bold position in the peptides. This assay was performed
with peptides synthesized on cellulose and a luminescent indicator strain (see Experimental Procedures). The first peptide is called Bac2A, and
the other two peptides are variants of Bac2A in which the third position (bold) is substituted by a Trp or Phe, respectively. The numbers in the
table are all relative EC50 values. All observed EC50 values are divided by the EC50 value of the parental peptide and, for comparison, normalized
by using the MIC whereby the MIC of the first peptide is 6.3-fold higher than for the next two peptides. Consequently, values higher than 6.3 for
the first peptide or 1 for the next two peptides correspond to weaker activity (relative to the parent peptide), and values lower than 6.3 for the first
peptide or 1 for the next two peptides correspond to stronger activities. Bold numbers represent peptides with antimicrobial activities against
Pseudomonas aeruginosa strain H1001 at least 30% stronger than the parent peptide.
a Data taken from Hilpert, 2005 [9]. Normalized according to the MICs of the parent peptides for P. aeruginosa. The MIC of Bac2A against wild-
type Pseudomonas aeruginosa was determined to be 50 mg/ml, whereas both variants of Bac2A showed an MIC of 8 mg/ml [9].restricted by the high cost and the time consumption to
synthesize larger quantities of peptides on resin. Peptide
arrays on cellulose provide an effective and relatively
inexpensive method for surveying large numbers of
peptide variants for particular activity determinants. Re-
cently, we reported the application of this technique [9]
to investigate the killing of Pseudomonas aeruginosa
strain H1001 [10]. Strain H1001 has a luciferase gene cas-
sette incorporated and can be used to monitor viability of
these bacteria. The peptides synthesized on a cellulose
support can be cleaved from the support by ammonia
gas; inserted and serially diluted into a microtiter plate.
Finally, the peptides are incubated with the indicator
bacterium at 37C, and luminescence is detected in
a time-dependent manner. In this paper, we have applied
this newly developed method to increase understanding
of the primary sequence requirements for short antimi-
crobial peptides (12 amino acids) in respect to killing
the pathogenic Gram-negative bacteriumP. aeruginosa.
Results and Discussion
Single Position Substitution Analyses
Previous studies utilized a complete substitution analy-
sis of the peptide Bac2A (RLARIVVIRVAR-NH2) to dem-
onstrate, for example, that Ala residues at positions 3
and 11 can be substituted by many other amino acids
[9]; with Arg, Phe, and Trp, in particular, being favored
at position 3. For example, exchanging Ala with Arg or
Trp at position 3 led to two Bac2A variants (R3 = RLRRIV-
VIRVAR-NH2 and W3 = RLWRIVVIRVAR-NH2) showing
superior minimal inhibitory concentrations (MICs) of
8 mg/ml against wild-type P. aeruginosa strain H103,
compared to 50 mg/ml for the parent peptide Bac2A [9].
To investigate whether different occupancy at position
3 favored particular substitutions at position 11, single-
position substitution analyses at position 11 for the pep-
tides Bac2A, R3, and W3 were analyzed for their ability to
kill P. aeruginosa strain H1001 (Table 1). Only substitu-
tions with the positively charged amino acids Arg and
Lys were able to universally improve activity relative to
the respective parent peptides, Bac2A, R3, or W3. For
Bac2A, substitutions of Ala with Arg, Cys, Gly, His, Lys,
Ile, Leu, and Tyr all improved activity, while most other
substitutions, with the exception of the acidic residues
Asp and Glu, were well tolerated. In case of peptideW3, where position 3 is filled with the hydrophobic amino
acid Trp, the activity decreased if position 11 was occu-
pied by another hydrophobic amino acid such as Phe>
Tyr>Trp/Ile>Thr and Val. Only substitutions with Lys
and Arg led to improved activity, while Asn and His
were well tolerated. In contrast, peptide R3, with a posi-
tively charged hydrophilic amino acid substituted at
position 3, was much better able to accommodate sub-
stitutions at position 11, including hydrophobic residues
like Phe/Tyr>Trp>Leu, as well as hydrophilic positively
charged ones such as Arg, His, or Lys, resulting in im-
proved activity, while only Asp and Glu were detrimental.
It is quite clear from these results that changes in any sin-
gle position of the peptide may impact on the preferred
residues at other positions in the peptide. Each single
substituted peptide variant may lead to different pre-
ferred substitutions at any other position, which was
chosen for optimization. Each of these variants could, in
principle, be used for a further optimization process, but
this would result in a very complex optimization strategy.
Luminescence-Based Killing Assay with Scrambled
Bac2A Peptides
To investigate the flexibility of amino acid arrangements
for creating active peptides, we decided to use a very
simple approach by scrambling the sequence of an
active peptide. Consequently 49 peptide variants of
Bac2A were created by a nonbiased random com-
puter-driven scrambling of sequences (Table 2). Each
of these variants were composed of the same amino
acids and had the same length, net charge, and amount
of hydrophilic and hydrophobic amino acids and thus
were ideally suited for testing the importance of the pri-
mary amino acid sequence for activity. For example, it
has been demonstrated that scrambling of a sequence
destroys sequence-specific interactions, as observed,
e.g., with antibodies recognizing linear epitopes. For
this type of sequence-specific interaction, scrambled
peptides are normally used as a negative control to
prove the sequence specificity. Conversely if amino
acid composition was the sole determinant of killing ac-
tivity, all scrambled peptides should be active.
Assessment of killing of P. aeruginosa by the scram-
bled peptides indicated that they fell into six different
activity classes (Table 2), whereby six were substantially
more active than Bac2A (activity class 1), four slightly
Short Antimicrobial Peptides
1103Table 2. Effect of Scrambled Variants of Bac2A on Antibacterial Activity against P. aeruginosa Strain H1001 as Assessed by the Rate of
Decrease of Luminescence
Peptide Sequence Activity Classa Peptide Sequence Activity Classa
Bac006 VRIRARRVILVA 1 Bac007 RRLVAIVAVRRI 4
Bac010 AAVRRRVRLVII 1 Bac011 AVRVRRRAILVI 4
Bac014 RAVAVIIRLRRV 1 Bac021 ARIARRVRILVV 4
Bac020 RRAAVVLIVIRR 1 Bac024 RAIIRRVLVRVA 4
Bac034 VRLRIRVAVIRA 1 Bac032 ARRARIRILVVV 4
Bac043 RVLIVIRARRVA 1 Bac036 RARRVRVLIAIV 4
Bac08 VLIRIRRVARAV 2 Bac037 RAIRVRRIVLAV 4
Bac016 RARIVRVRVILA 2 Bac041 RLRVAIVAIVRR 4
Bac018 RRVAIVVIARLR 2 Bac048 VVRALRRIIARV 4
Bac029 IILAVRAVRRVR 2.5 Bac023 RRRAIVRVVAIL 4.5
Bac2A RLARIVVIRVAR 3 Bac030 IVVRRRRAALVI 4.5
Bac002 RRIARVIVAVLR 3 Bac003 ARRLIVRVRVIA 5
Bac004 IRARIAVRRVVL 3 Bac009 IIRAALRRVRVV 5
Bac005 IVRVAVALRRIR 3 Bac017 VILARRRVRIAV 5
Bac012 IAARRLIRVVRV 3 Bac019 ILVARVIRRRVA 5
Bac013 VARIVVRLIRAR 3 Bac028 VIVRLAARRVRI 5
Bac015 AVRAIRVLRVIR 3 Bac031 LAIVRRARVRIV 5
Bac025 ARAILIRVVRRV 3 Bac033 IRVRRLVAAVIR 5
Bac026 IARRIVAVRLRV 3 Bac035 RVLRVVRAAIRI 5
Bac042 ILVIVRRRARAV 3 Bac038 VVIRAAIRRVRL 5
Bac045 VIALRIAVRRVR 3 Bac039 RIVLRRAAVIRV 5
Bac046 RRRVIVAVLARI 3 Bac040 VLARVVARRIRI 5
Bac047 RVLIAARVIRRV 3 Bac027 RVLIARVVRAIR 5.5
Bac049 VIALVRARVRRI 3 Bac022 ILRRVRVRAVAI 6
Bac050 RRVIAIAVRRLV 3 Bac044 VIRRRRILAAVV 6
a The table is ordered by the activity classes as follows: class 1, peptides showing stronger killing than Bac2A at a 4- to 8-fold higher dilution;
class 2, peptides showing stronger killing compared to that of Bac2A at a 4-fold higher dilution; class 3, peptides similar to Bac2A; class 4, pep-
tides similar to Bac2A at the highest concentration but demonstrating weaker killing at a 2-fold dilution; class 5, peptides giving very weak or no
killing at a 2-fold dilution; class 6, peptides with weak killing activity at the highest peptide concentration.more active (activity class 2), 14 showed similar activity
(activity class 3), 11 showed slightly lower activity (activ-
ity class 4), 12 lower activity (activity class 5), and two
were completely inactive (activity class 6). Examination
of the sequences within a given activity class demon-
strated that peptides that varied substantially from the
primary amino acid-specific sequence of Bac2A were
able to kill P. aeruginosa. These data therefore clearly
showed that there were no sequence-specific interac-
tions and thus favored a scenario whereby, in addition
to the appropriate amino acid composition, there is
one or more additional features that determined activity.
A similar observation with an a-helical antimicrobial
peptide was made in that a scrambled variant of a wild-
type peptide showed a similar or stronger activity
against different bacterial strains [11].
To confirm these data and the observed activity clas-
ses, three of the most active class 1 peptides and two
of the least active class 6 peptides were chosen to be
synthesized on resin. The minimal inhibitory concentra-
tions (MIC) were determined for the important medical
bacterial pathogens P. aeruginosa, E. coli, Salmonella
typhimurium, S. aureus, S. epidermidis, and E. faecaelis
and the yeast Candida albicans. The measured MIC
values (Table 3) confirmed the classification of the pep-
tides. All three activity class 1 peptides showed lower
MICs than Bac2A against Pseudomonas aeruginosa,
with the best being about 7-fold more active. The two
activity class 6 peptides showed an MIC that was at least
5-fold higher than Bac2A. The MICs for P. aeruginosa
grown under high and low magnesium conditions dem-
onstrated the same 4-fold difference in MIC for both
Bac2A and the activity class 1 peptides (data not shown),indicating that increased activity reflected more than just
decreased antagonism by divalent cations.
The data indicate that the tactic of scrambling a pep-
tide sequence is potentially useful as an optimization
approach for short linear antimicrobial peptides. This
easy and rapid approach opens up novel possibilities
to enrich the pool of excellent candidate peptides that
can then be further optimized or screened for other de-
sired qualities, like bioavailability, nontoxicity, stability,
and solubility.
QSAR Computational Analysis
Sequence alignments of the scrambled Bac2A peptides
failed to demonstrate any correlation between peptide
sequence and activity. This result supports the hypoth-
esis that there is no sequence-specific interaction in-
volved in killing activity against bacteria. To identify
any general structural or molecular properties that might
correlate with activity, a QSAR computational analysis
with the program MOE (Chemical Computing Group,
Inc.) was performed. For this analysis, peptides were
separated into two major pools: active (similar or better
than Bac2A) and less active peptide variants (worse than
Bac2A). Given the lack of three-dimensional structures
and the similar composition of the peptides (same
scrambled sequence), descriptors were developed
that related to sequence ordering and fragment-based
hydrophobicity. A classification model (Figure 1) was
developed on the basis of these descriptors [12] and
demonstrated that the active peptides could be classi-
fied on the basis of the distance between the middle
two Arg residues and possession of a certain hydropho-
bicity (>2) in a span of five consecutive residues
Chemistry & Biology
1104Table 3. Determination of the Minimal Inhibitory Concentrations in Mueller-Hinton Media for Five Different Bacteria and the Yeast Candida
albicans
Sequencea Name Rel. EC50
b
Minimal Inhibitory Concentrations (MIC) (mg/ml)
P. aeruginosa E. coli Salmonella S. aureus S. epidermidis C. albicans
RLARIVVIRVAR Bac2A 50 17 34 17 4 9
RAVAVIIRLRRV Bac014 23 11 11 23 6 6
RRAAVVLIVIRR Bac020 11 6 23 11 1.5 11
ILRRVRVRAVAI Bac022 250 136 250 >250 136 250
VIRRRRILAAVV Bac044 >250 136 136 250 136 136
VRLRIRVAVIRA Bac034 1 25 3 12 25 3 12
VRFRIRVAVIRA F3 0.89 6 1.6 6 12 1.6 6
VRWRIRVAVIRA W3 0.66 6 1.6 6 12 1.6 12
VRLWIRVAVIRA W4 1.89 >50 6 >50 50 3 50
VRLRIRVAVRRA R10 0.81 12 6 6 12 1.6 6
VRLRIRVAVIRK K12 0.48 6 3 6 6 1.6 3
VQLRIRVRVIRK opt1 6 3 6 12 1.6 6
VRLRIRVRVIRK opt2 3 1.6 6 6 0.8 3
KQFRIRVRVIRK opt3 6 3 6 12 1.6 6
KRFRIRVRVIRK opt4 6 1.6 3 6 0.8 12
KRWRIRVRVIRK opt5 3 1.6 3 3 0.8 6
The MICs are given as the most frequently observed value except for Bac2A, which is an average value of all measurements obtained with this
peptide (frequently used as a control). The values are rounded to achieve full numbers.
a All peptides had an amidated C terminus.
b Proxy EC50 from Figure 4 for the single substitution peptides only.somewhere in the molecule (a so-called hydrophobic
patch) and, in some cases, the specific presence of
a Val or Leu residue at the beginning of the hydrophobic
patch. These descriptors implicate global hydrophobic-
ity as opposed to position-specific hydrophobicity, indi-
cating that according to this model, the position of the
hydrophobic patch is not relevant to activity.
For the ten peptides that had better activity than
Bac2A, a similar model-building exercise yielded a
model with an accuracy of 95% that indicated that the
best activity was favored by a hydrophobic patch and
a predicted water-accessible surface area of all atoms
with a partial charge <0.2 (data not shown); however,
the number of active peptides was insufficient for crea-
tion of a robust model.
Structure/Activity Relationships for Selected
Peptides
The hydrophobic patch found by the QSAR analysis is
consistent with the requirement of certain necessarystructural features for activity of the scrambled pep-
tides. It has been shown that the activity of many pep-
tides, including bactenecin and a linear version thereof,
is driven by membrane interaction, which involves the
induction of a defined peptide structure [8, 13]. Thus it
seemed likely that one purpose of the hydrophobic
patch referred to above would be in conjunction with
membrane interaction. (A recent discussion of the inter-
actions of antimicrobial peptides with model phospho-
lipids membranes was presented by Papo and Shai
[14].) To determine if the activity of the scrambled pep-
tide variants reflected differences in membrane interac-
tion, CD spectrometry was performed in buffer and in
anionic liposomes. In Tris buffer (Figure 2A), all the
peptides demonstrated a typical random structure. In
liposomes (Figure 2B), the activity class 1 peptides dem-
onstrated spectra typical of b structures, whereas both
activity class 6 peptides displayed more unstructured
spectral characteristics at all liposome concentrations
used. This is consistent with the suggestion that thoseFigure 1. QSAR Modeling
The peptide sequences were analyzed by
assessing which of several descriptors
were effective for grouping, into separate
classes, the active and inactive/less-active
peptides. Using the binary classification al-
gorithm of the model-building program
MOE (Chemical Computing Group, Inc.),
a set of differentiating criteria were deter-
mined as outlined in the figure. In particular,
it was apparent that the active peptides were
included in three main subsets: subset 1 was
characterized by all peptides with a nonhy-
drophobic tail (S310% 20.38) and with an in-
ternal hydrophobic ‘‘patch’’ characterized by
a maximum hydrophobicity S310 over five
residues (Max S5) of >2. Hydrophobicity (S310) was determined according to the Eisenberg hydrophobicity scale [21]. This division correctly
predicted the activity of 16/18 peptides. Peptides with a more hydrophobic C-terminal tail were further subdivided in subset 2 by the presence
of a small internal hydrophobic patch between the second and third arginine residues (D2 > 2.5), which yielded a correct prediction for four
of six active peptides. The two active peptides among the remaining 18 peptides were manually classified in subset 3 based on their
‘‘FirstResidue’’ parameter being = 0 (see Experimental Procedures). Overall, 21/25 active peptides and 22/25 inactive peptides were correctly
classified with this model, leading to a classification accuracy of 74% for both active and inactive peptides.
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interact with membranes.
Since liposomes are simplified models of biological
membranes, an additional assay was performed with
living bacteria and biologically intact membranes. Deter-
mination of the ability of peptides to depolarize the
cytoplasmic membrane, which occurs with most antimi-
crobial peptides at high enough concentrations, thus
permits the direct assessment of peptide interaction
with bacterial membranes, and this can be monitored
by the dequenching of the fluorescent probe diSC35
[15]. The peptide Bac2A and all activity class 1 peptides
were able to rapidly depolarize the membrane of
S. aureus, with similar rates to the positive control gram-
icidin S (Figure 3A). In contrast, less active class 6 pep-
tides showed a much reduced ability to depolarize the
membrane. Similar results were achieved with Gram-
negative bacterium E. coli strain DC2 (Figure 3B). Thus,
these data are consistent with the proposal that peptide
activity is influenced by the ability to interact with the
bacterial membranes by adopting certain structural fea-
tures that are embedded in the peptide sequence.
Using Scrambled Peptides for Additional
Optimization Process
The screening of the scrambled Bac2A peptides repre-
sented a new approach to optimization. To gain even
more strongly active peptides, a second optimization
approach was used for one of the best scrambled pep-
tides (Bac034) by using a substitution analysis synthe-
sized on cellulose. The killing activity of all these pep-
tides was determined with P. aeruginosa strain H1001
Figure 2. Structural Characterization of Different Scrambled Pep-
tides by Circular-Dichroism Spectroscopy
(A and B) Spectra in 10 mM Tris buffer (pH 7.4) (A), or spectra in
liposomes (POPG/POPC 1:1) (B).as described above (Figure 4) (N.B., Cys was omitted
in this series due to concerns about its tendency to
form covalent dimers). The core amino acid residues
Ile-5, Arg-6, and Val-7 and also Arg-11 proved to be
very important for killing activity. Substitutions of the
original amino acid residues in peptide Bac034 with
the structure disrupting amino acids Pro and Gly at po-
sitions 4, 5, 6, 7, and 9 led to a strong decrease in activ-
ity. These results tend to indicate that there are impor-
tant structural features at these positions in the center
of the molecule that help to determine antimicrobial ac-
tivity. Also, certain amino acid positions demonstrated
substantial flexibility in substitutions including the C-
terminal residue Ala-12 and Ala-8 that could be opti-
mized with 5 and 7 favored substitutions, respectively.
Five peptides were chosen to validate the substitution
analysis, demonstrating that the proxy EC50 used to as-
sess relative efficiency in decreasing luminescence rep-
resented a reasonable method of assessing improved
killing activity in peptides. The peptide K12 in particular
had a very good broad spectrum activity profile. Using
the information from the Bac034 analysis, we chose se-
lected substitutions to be combined to design new pep-
tides (Table 3). Opt5 in particular had excellent broad
spectrum activity. The results demonstrated that the
creation of improved antimicrobial peptides could be
Figure 3. Membrane Depolarization Assay
Gramicidin S (solid line), Bac2A (long dash), Bac014 (dash dot),
Bac020 (long dash dot dot), Bac022 (long dash dot), Bac034 (round
dot), and Bac044 (dash) were used to determine the mechanism of
action of peptides as assessed by measuring the ability to depolar-
ize S. aureus cells (A) or E. coli strain DC2 (B) with the membrane-
potential-sensitive dye diSC35. Either 20 mg/ml of peptides or, as a
positive control, 29 mg/ml of gramicidin S were added. The fluores-
cence values were measured every 5 s. Smoothed lines were used
to describe the data points.
Chemistry & Biology
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The first two columns give the position (indicated as the row number) and the one-letter code sequence of the original peptide Bac034. The
second row gives the amino acids substituted at each amino acid position. For example, the peptide in the upper left-hand corner (column 3,
row 3) is ARLRIRVAVIRA. The results presented within each box represent the relative EC50 value, determined by treatment of the lux reporter
strain H1001 with peptide for 4 hr. Results are color coded as black, superior activity to the parent peptide Ba034; dark gray with white let-
tering, equivalent activity to the parent peptide Bac034; light gray with black lettering, inferior activity to the parent peptide Bac034; white, very
little activity.successfully achieved by starting from a single template
(Bac2A), by first scrambling the sequence (Bac020,
Bac034, and others), and then by using a substitution
matrix to improve the activity by single or multiple amino
acid substitutions (K12, opt 5, and others). This new pro-
cess, combined with the dramatic reduction in both cost
of the peptides and assay time, may help to improve the
speed of development of a broad range of new peptide-
based antimicrobial drugs against antibiotic resistance
bacteria.
Significance
Short antimicrobial peptides are promising candidates
for overcoming the critical and acceleratingproblemof
bacterial resistance to currently utilized antibiotics.
Despite the fact that the first antimicrobial peptide is
close to clinical approval, little is known about the
primary sequence requirements of short nonhelical
peptides. To provide a road map for development of
improved second generation therapeutics, we have
investigated in this study these sequence require-
ments by using scrambled peptides, QSAR modeling,
and substitution analyses. The resultant study adds
significantly to the field, demonstrating that the com-
plexity of primary amino acid sequence requirements
is much higher than previously anticipated and, for
the first time in an unbiased fashion, has revealed in-
triguing structure activity relationships. Our newly de-
scribed time- and cost-efficient optimization strategies
will have a strong impact on the development of new
drugs through the rapidenrichmentof leadcandidates.
Experimental Procedures
Strains
For the screening assay, a mini-Tn5-lux fliC::luxCDABE mutant
strain H1001 of P. aeruginosa PAO1 was utilized. This strain con-
tained a transcriptional fusion resulting in constitutive expression
of luciferase [10]. The bacterial strains used for the antimicrobial ac-
tivity assay included E. coli UB1005 (F2, nalA37, metB1), a wild-type
Salmonella enterica ssp. Typhimurium (S. typhimurium), wild-typePseudomonas aeruginosa (P. aeruginosa) H103, Enterococcus fae-
calis (E. faecalis) ATCC29212, Staphylococcus aureus (S. aureus)
ATCC25923, and a clinical isolate of Staphylococcus epidermidis
(S. epidermidis) obtained from Dr. D. Speert (Department of Pediat-
rics, UBC). Antifungal activity was tested with a lab isolate of Can-
dida albicans (C. albicans) obtained from Dr. B. Dill (Department of
Microbiology and Immunology, UBC).
Peptide Synthesis
Peptide syntheses on cellulose were performed with a pipetting ro-
bot (Intavis, Ko¨ln, Germany) and Whatman 50 cellulose membranes
(Whatman, Maidstone, United Kingdom) by using two glycine resi-
dues as a linker, as described previously [16, 17]. For further charac-
terization, free peptides were synthesized by Fmoc chemistry in our
labs (Humboldt-Universita¨t, Berlin) or purchased from Thermohy-
baid (Thermo-Electron-Corporation; Ulm, Germany). The peptide
concentration was estimated from the weighed sample. Advantages
and disadvantages for the peptide spot synthesis were discussed
previously [9].
Minimal Inhibitory Concentration Determination
The minimal inhibitory concentration (MIC) of the peptides was mea-
sured by a modified broth microdilution method [6] in Mueller-Hinton
(MH) medium. After incubation at 37C for 12–15 hr, the MIC was
taken as the concentration at which no growth was observed.
Screening Assay for the Peptides from Cellulose Support
The peptides were cleaved from the dried membrane in an ammonia
atmosphere overnight, resulting in free peptides with an amidated C
terminus. The liberated peptides were amidated and contained two
glycines at the C terminus due to the linker between the cellulose
membrane and the peptide sequence. The peptide spots were
punched out and transferred in a 96-well microtiter plate. The active
wild-type peptide and an unrelated peptide (GATPEDLNQKLS) were
used as positive and negative controls, respectively. An overnight
culture of P. aeruginosa strain H1001 was diluted 1:500 with
100mM Tris buffer (pH 7.3), 20mM glucose and was added to the
wells (100 ml/well) containing the peptide spots. After 30 min incuba-
tion time to resolve the peptides from the cellulose support, serial di-
lutions were carried out from the membrane spots. The lumines-
cence produced by the FMN-dependent luciferase system was
detected in a time-dependent manner with a Tecan Spectra Fluor
plus (Tecan U.S., Inc., Durham, NC).
Circular-Dichroism Spectroscopy
Circular-dichroism (CD) spectra were recorded with a Jasco J-810
spectropolarimeter (Tokyo, Japan). Spectra were measured
Short Antimicrobial Peptides
1107between 190 and 250 nm at a scan speed of 10 nm/min and a total of
ten scans per sample, with a quartz cell with 1 mm path length at
room temperature. The data were collected and processed with
Jasco software. The peptide concentration used was 70 mM. Spec-
tra were recorded in 10 mM Tris buffer (pH 7.3) and in unilamellar
liposomes made by extrusion of a 1:1 mixture of 1-palmitoyl-
2-oleoyl-sn-glycero-3-phosphocholine (POPC) and 1-1-palmitoyl-
2-oleoyl-sn-glycero-3-phosphoglycerol (POPG). In all cases, the
spectrum in the absence of peptide was subtracted from that in
the presence of peptide.
Membrane Depolarization
To assess bacterial membrane depolarization, a membrane-poten-
tial-sensitive dye, diSC35, was used [15] as described previously
[18, 19]. This cationic dye concentrates in the cytoplasmic membrane
under the influence of the membrane potential (which is oriented in-
ternal negative) resulting in a self-quenching of fluorescence. Upon
disruption of the membrane potential, the dye dissociates into the
buffer, leading to an increase in fluorescence [13]. Depolarization
was monitored over a period of 900 s with 20 mg/ml peptide or 29
mg/ml gramicidin S in a Luminescence Spectrometer LS50B (Perkin
Elmer, Woodbridge, Canada) at room temperature. The depolariza-
tion of the cytoplasmic membrane was determined with the Gram-
positive bacterium S. aureus ATCC 25923 and the Gram-negative
bacterium E. coli DC2 mutant with increased outer membrane per-
meability [20] to permit the dye to reach the cytoplasmic membrane.
Computational Analyses
The peptide sequences were analyzed with the program MOE
(Chemical Computing Group, Inc.). Given the qualitative nature of
the data, a classification model [12] was derived in an attempt to dis-
cern the difference between active (activity classes 1, 2, and 3) and
inactive (activity classes 4, 5, 6) peptides. The three-dimensional
structures of these peptides were not known, thus descriptors
based on exact spatial relationships could not be used. Moreover,
due to the nature of the scrambled sequences, many of the tradi-
tional two-dimensional descriptors did not discriminate between
the peptides (e.g., net charge, logP, etc.). Therefore, a number of de-
scriptive indices related specifically to sequence ordering and hy-
drophobicity were derived including: (1) distance between the first
and second (D1), second and third (D2), and third and fourth (D3) ar-
ginines measured as the number of residues separating them; (2) the
maximum and average distance between any two consecutive argi-
nines (Dmax, Davg); (3) water accessible surface area of all hydro-
phobic (|qi| < 0.2) atoms (ASA_H); (4) hydrophobicity using the Eisen-
berg scale [21] measured over consecutive strings (S) of three, four,
or five residues of the peptide (S3x, S4x, S5x) and maximum and
minimum values of the hydrophobicity scale (e.g., S4max, S4min,
etc.); (5) the maximal stretch of hydrophobic residues (count H) or
the presence of a string of six hydrophobic amino acids including al-
anine (6HA); and (6) the presence of a string of four amino acids,
preferably beginning with isoleucine (first residue: 1 = YES, 0 = string
begins with V or L instead of I, 2 = NO).
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